These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
308 related items for PubMed ID: 3107989
21. Flecainide and CAST. Lancet; 1989 Aug 26; 2(8661):481-2. PubMed ID: 2570188 [No Abstract] [Full Text] [Related]
22. An interim perspective on the removal of encainide and flecainide from the cardiac arrhythmia suppression trial. Coyle JD, Schaal SF. DICP; 1989 Jun 26; 23(6):478-9. PubMed ID: 2500783 [No Abstract] [Full Text] [Related]
23. Reversal of proarrhythmic effects of flecainide acetate and encainide hydrochloride by propranolol. Myerburg RJ, Kessler KM, Cox MM, Huikuri H, Terracall E, Interian A, Fernandez P, Castellanos A. Circulation; 1989 Dec 26; 80(6):1571-9. PubMed ID: 2480856 [Abstract] [Full Text] [Related]
27. Effect of encainide and flecainide on chronic ectopic atrial tachycardia. Kunze KP, Kuck KH, Schlüter M, Bleifeld W. J Am Coll Cardiol; 1986 May 26; 7(5):1121-6. PubMed ID: 3082957 [Abstract] [Full Text] [Related]
30. Antiarrhythmic efficacy, clinical electrophysiology, and pharmacokinetics of 3-methoxy-O-desmethyl encainide (MODE) in patients with inducible ventricular tachycardia or fibrillation. Roden DM, Lee JT, Woosley RL, Echt DS. Circulation; 1989 Nov 26; 80(5):1247-58. PubMed ID: 2805262 [Abstract] [Full Text] [Related]
31. Comparison of the efficacy of newly developed antiarrhythmic drugs in the treatment of ventricular tachyarrhythmias. Hellestrand KJ. Eur Heart J; 1984 Sep 26; 5 Suppl B():87-94. PubMed ID: 6437822 [No Abstract] [Full Text] [Related]
32. Possible contribution of encainide metabolites to the long-term antiarrhythmic efficacy of encainide. Winkle RA, Peters F, Kates RE, Harrison DC. Am J Cardiol; 1983 Apr 26; 51(7):1182-8. PubMed ID: 6404150 [Abstract] [Full Text] [Related]
33. From the Food and Drug Administration. Nightingale SL. JAMA; 1989 Jun 16; 261(23):3368. PubMed ID: 2498536 [No Abstract] [Full Text] [Related]
35. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. Cardiac Arrhythmia Suppression Trial (CAST) Investigators. N Engl J Med; 1989 Aug 10; 321(6):406-12. PubMed ID: 2473403 [Abstract] [Full Text] [Related]
36. Comparisons of efficacy and tolerance of moricizine with other antiarrhythmic agents in the treatment of chronic ventricular arrhythmias. Anderson JL. Am J Cardiol; 1990 Feb 20; 65(8):32D-40D. PubMed ID: 2106254 [Abstract] [Full Text] [Related]
37. Response to encainide of refractory ventricular tachycardia: clinical application of assays for parent drug and metabolites. Anderson JL, Stewart JR, Johnson TA, Lutz JR, Pitt B. J Cardiovasc Pharmacol; 1982 Feb 20; 4(5):812-9. PubMed ID: 6182414 [Abstract] [Full Text] [Related]
38. Investigational antiarrhythmic drugs for the treatment of ventricular rhythm disturbances. Pratt CM, Luck JC, Mann DE, Wyndham CR. Cardiol Clin; 1984 Feb 20; 2(1):35-46. PubMed ID: 6443563 [Abstract] [Full Text] [Related]